Stay updated on SAGE-217 in Parkinson's Disease: Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 in Parkinson's Disease: Clinical Trial page.

Latest updates to the SAGE-217 in Parkinson's Disease: Clinical Trial page
- Check5 days agoChange DetectedA site-wide NIH notice about terminology changes under Executive Order 14434 appears above the 403 error page. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden response instead of study details.SummaryDifference0.2%

- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header, and many study-related links and documents have been removed, blocking access to the study record.SummaryDifference26%

- Check40 days agoChange DetectedRevision label on the page was updated from v3.6.6 to v3.7.0, indicating a metadata/template update rather than changes to the study information or eligibility details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6. This indicates a minor metadata update to the page without altering study details or content.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision bumped from v3.6.4 to v3.6.5, indicating a minor update to the page template. No visible changes to the Study Details content.SummaryDifference0.0%

Stay in the know with updates to SAGE-217 in Parkinson's Disease: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 in Parkinson's Disease: Clinical Trial page.